A Two-Centre, Randomised, Double-Blind, Double-Dummy, Placebo-Controlled, 3-Period Cross-Over Study to Evaluate the Effect of Treatment With Repeat Doses of GW274150 on the Allergen-Induced Late Asthmatic Response in Subjects With Mild Asthma.
Phase of Trial: Phase I
Latest Information Update: 01 Jun 2012
At a glance
- Drugs GW 274150; Montelukast
- Indications Asthma
- Focus Pharmacodynamics
- Sponsors GlaxoSmithKline
- 24 Mar 2009 Actual initiation date changed from Jan 2005 to Nov 2004; trial phase changed from II to I as reported by ClinicalTrials.gov.
- 09 Mar 2008 Status change
- 05 Sep 2006 New trial record.